Navigation Links
Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer
Date:9/23/2007

(PHILADELPHIA) Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson and Thomas Jefferson University Hospital in Philadelphia have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system, which is made by Nucletron, a technology company based in The Netherlands, is only being used for imaging and planning purposes so far, it ultimately will help with the actual placement of the seeds. To date, Jefferson is the first medical center in the Delaware Valley to begin employing the new system.

The multidisciplinary team of urologists, surgeons, radiation oncologists, radiation physicists and others involved in using the device are hoping that the new federal Food and Drug Administration-approved technology will make an already good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill.

The device is a step above the traditional technique because it makes use of a more sophisticated approach that allows for a coordinated, real-time imaging-based implantation of seeds, Richard Valicenti, M.D., associate professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University, says about the Nucletron device.

Patients have two options for treatment for localized, low-risk prostate cancer confined to the prostate: surgery or radiation therapy. In brachytherapy, tiny pellets seeds about the size of a grain of rice blanket the prostate, giving off radiation that travels only a few millimeters to kill nearby cancer cells. The seeds are carefully placed inside the cancerous tissue and positioned to efficiently attack the cancer. Brachytherapy has been proven to be very effective and safe, providing a good alternative to surgical removal of the prostate, while reducing the risk of certain long-term side effects, such as impotence. The seed radioactivity decays with time, while the seeds stay within the treatment area.

This new approach is automated, so what normally takes us many steps to do we can do very quickly, he says, noting that brachytherapy is highly operator-dependent. For example, putting in the rectal ultrasound probe has to be done slowly by hand. Now, the device does it and takes measurements of the size and location automatically of the target gland. It collects the imaging information the dimensions of the patients prostate and downloads this into a computer system, where it is rapidly processed.

The doctors, radiation physicists and other specialists then specify the parameters of treating the cancer, such as how much dose to give the prostate, how much extra dose to give to the area of the tumor and the positions in which to give the radiation, all in less time than previously possible with standard techniques, Dr. Valicenti says.

Up until recently, we would produce a plan in the outpatient setting that we hoped to recapitulate in the operating room, explains Adam Dicker, M.D. Ph.D., professor of radiation oncology at Jefferson Medical College. But there was always the concern that what we saw initially might not match the situation later. Planning, he explains, can be affected by the patients position and the location and condition of his prostate.

Because the device enables real-time planning in the operating room, he says, If an area is under-dosed, you can find out right away and make corrections. The system provides a multidimensional view of the prostate and the ability to process and accumulate more precise information, constantly updating and readjusting the treatment plan.


'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Jefferson Physicians Report on Potentially Fatal Complication of Heart Attack
2. Jefferson Researchers Want to Learn If Heart Defect at Heart of Some Migraines
3. Antioxidants protect health tissue in people undergoing radiation therapy.
4. Radiation for Bone Pain
5. Radiation for Bone Pain
6. Gene enchances radiation therapy - A novel approach to fight cancer
7. Radiation before surgery cuts cancer recurrence
8. UV Radiation induces Melanoma
9. Low-radiation treatment for brain tumours
10. Lack of solar radiation causes cancer
11. Microwave radiation has no hazards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 30, 2016 , ... Mercy College is expanding its Graduate Business Programs to ... expanding due to high demand: Master of Business Administration (MBA), Master of Organizational Leadership ... , School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe ...
(Date:4/29/2016)... ... 2016 , ... Memorial Healthcare System Graduate Medical Education ... that it has received accreditation for its residency program on Physical Medicine and ... Memorial is currently pursuing, including Pediatrics and Internal Medicine. This accreditation allows the ...
(Date:4/29/2016)... ... 29, 2016 , ... On Tuesday, April 26, 2016 members of the HomeTown ... of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. , ... 70% tax credit to individuals and corporations which donate directly to a “rural hospital” ...
(Date:4/29/2016)... VA (PRWEB) , ... April 29, 2016 , ... ... with student loans more flexibility in repaying their loans, more information about their ... a time when total outstanding student loan debt, including federal and private loans, ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... India , April 29, 2016 ... Pipeline Review, H1 2016" market research report that ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:4/29/2016)... , April 29, 2016 Glycotope ... expertise, today announces the appointment of Dr. Alfredo ... Zurlo is an oncologist with many years clinical experience ... biotechnology industries. His last role was at Mologen AG ... the Executive Board. Previously Dr. Zurlo held various positions ...
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
Breaking Medicine Technology: